Study on 'The Use of Non-contrast Helical Computerized Tomogram in Predicting Treatment Outcomes of Upper Ureteric Stone by Extracorporeal Shock Wave Lithotripsy Using the Sonolith 4000+ Lithotripter'

Sponsor
Hospital Authority, Hong Kong (Other)
Overall Status
Completed
CT.gov ID
NCT00517205
Collaborator
(none)
100
1
38
2.6

Study Details

Study Description

Brief Summary

The purpose of this research is to assess the role of non-contrast helical computerized tomogram in predicting the treatment outcome of upper ureteric stone by extracorporeal shock wave lithotripsy (ESWL).

Condition or Disease Intervention/Treatment Phase
  • Procedure: Non-contrast helical computerized tomogram (NCHCT)

Study Design

Study Type:
Observational
Anticipated Enrollment :
100 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
The Use of Non-contrast Helical Computerized Tomogram in Predicting Treatment Outcome of Upper Ureteric Stone by Extracorporeal Shock Wave Lithotripsy Using the Sonolith 4000+ Lithotripter
Study Start Date :
Oct 1, 2004
Actual Study Completion Date :
Dec 1, 2007

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Inclusion Criteria:
    • Adult patient (> 18 years old)

    • With solitary upper ureteric stone (defined as ureter above the sacroiliac joint as seen on plain radiography) diagnosed by NCHCT ( can have stones at the other site but the indexed stone is a solitary stone)

    • Size 5 to 15 mm in the maximal diameter as measured from plain radiography.

    • Planned for primary in-situ ESWL

    Exclusion Criteria:
    • Patient contraindicated for ESWL - active urosepsis, coagulopathy, pregnant lady etc

    • Presence of percutaneous nephrostomy or ureteric stent

    • Suspected distal obstruction

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Prince of Wales Hospital Hong Kong China

    Sponsors and Collaborators

    • Hospital Authority, Hong Kong

    Investigators

    • Principal Investigator: Chi Fai Ng, Dr, Department of Surgery, Division of Urology, The Chinese University of Hong Kong

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00517205
    Other Study ID Numbers:
    • CRE-2004.309
    • HARECCTR0500008
    First Posted:
    Aug 16, 2007
    Last Update Posted:
    Jun 16, 2011
    Last Verified:
    Jun 1, 2011
    Keywords provided by , ,
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 16, 2011